Estimating the global burden of endemic canine rabies
- PMID: 25881058
- PMCID: PMC4400070
- DOI: 10.1371/journal.pntd.0003709
Estimating the global burden of endemic canine rabies
Erratum in
-
Correction: Estimating the global burden of endemic canine rabies.PLoS Negl Trop Dis. 2015 May 11;9(5):e0003786. doi: 10.1371/journal.pntd.0003786. eCollection 2015 May. PLoS Negl Trop Dis. 2015. PMID: 25961848 Free PMC article. No abstract available.
Abstract
Background: Rabies is a notoriously underreported and neglected disease of low-income countries. This study aims to estimate the public health and economic burden of rabies circulating in domestic dog populations, globally and on a country-by-country basis, allowing an objective assessment of how much this preventable disease costs endemic countries.
Methodology/principal findings: We established relationships between rabies mortality and rabies prevention and control measures, which we incorporated into a model framework. We used data derived from extensive literature searches and questionnaires on disease incidence, control interventions and preventative measures within this framework to estimate the disease burden. The burden of rabies impacts on public health sector budgets, local communities and livestock economies, with the highest risk of rabies in the poorest regions of the world. This study estimates that globally canine rabies causes approximately 59,000 (95% Confidence Intervals: 25-159,000) human deaths, over 3.7 million (95% CIs: 1.6-10.4 million) disability-adjusted life years (DALYs) and 8.6 billion USD (95% CIs: 2.9-21.5 billion) economic losses annually. The largest component of the economic burden is due to premature death (55%), followed by direct costs of post-exposure prophylaxis (PEP, 20%) and lost income whilst seeking PEP (15.5%), with only limited costs to the veterinary sector due to dog vaccination (1.5%), and additional costs to communities from livestock losses (6%).
Conclusions/significance: This study demonstrates that investment in dog vaccination, the single most effective way of reducing the disease burden, has been inadequate and that the availability and affordability of PEP needs improving. Collaborative investments by medical and veterinary sectors could dramatically reduce the current large, and unnecessary, burden of rabies on affected communities. Improved surveillance is needed to reduce uncertainty in burden estimates and to monitor the impacts of control efforts.
Conflict of interest statement
LC, AK and MA are employed by Sanofi Pasteur and CS is employed by Merial. This does not alter our adherence to all PLOS NTDs policies on sharing data and materials. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Figures





Comment in
-
Rabies kills 59,000 people worldwide each year, study estimates.BMJ. 2015 Apr 23;350:h2189. doi: 10.1136/bmj.h2189. BMJ. 2015. PMID: 25908640 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous